degraders and further highlight the importance of selecting suitable E3 members to achieve effective cellular activity.
Zhang X, He Y, Zhang P, Budamagunta V, Lv D, Thummuri D, Yang Y, Pei J, Yuan Y, Zhou D, Zheng G. (2020). PROTACs as potent degraders across multiple cancer cell lines. European journal of medicinal chemistry, (199)
MIDAS Coordination Center
Contact us: email@example.com
Thank you to NIGMS Grant U24GM132013 for supporting the work at the Coordination Center.
Copyright MIDAS © 2022. All Rights Reserved.